RxDoctor Payments Data

Divyasri Gongireddy

Psychiatry · Chicago, ILNPI 1053731802

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations.

$1,621in general payments, 2019–2025

Across 72 payments — averaging $22.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$359
  • Otsuka America Pharmaceutical, Inc.$339
  • Lundbeck LLC$144
  • Johnson & Johnson$105
  • Takeda Pharmaceuticals U.S.A., Inc.$92
  • Teva Pharmaceuticals USA, Inc.$90
  • plus $491 from 14 others

What the payments were for

  • Food & beverage$1,621100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,621 in reported general payments places this provider in the 80th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois →

Other psychiatry in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →